Cargando…

Identification of an IDO1‐based immune classifier for survival prediction of upper tract urothelial carcinoma

The limited response rate of immunotherapy in upper tract urothelial carcinoma (UTUC) might be attributed to additional immunosuppressive mechanisms in vivo. As a promising immune checkpoint target, the expression and prognostic role of indoleamine 2,3‐dioxygenase 1 (IDO1) in UTUC remains unknown. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Wenlong, Yang, Meng, Cheng, Sida, Hou, Weibin, Wang, Bo, Chen, Junyu, Yu, Hao, Ouyang, Yi, Wang, Xiaofei, Ou, Ziwei, Xu, Peiqi, Li, Xuesong, Zhou, Liqun, Huang, Jian, Wang, Chunhui, Lin, Tianxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898711/ https://www.ncbi.nlm.nih.gov/pubmed/34962030 http://dx.doi.org/10.1111/cas.15253

Ejemplares similares

Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study)
por: Cheng, Sida, et al.
Publicado: (2021)

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy
por: Zhong, Wenlong, et al.
Publicado: (2017)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

Role of lymph node dissection in the management of upper tract urothelial carcinomas: a meta-analysis
por: Guo, Runqi, et al.
Publicado: (2018)

Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma
por: Li, Xiaoying, et al.
Publicado: (2020)

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status
por: Zhang, Lei, et al.
Publicado: (2014)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

Identification of Germline Mutations in Upper Tract Urothelial Carcinoma With Suspected Lynch Syndrome
por: Guan, Bao, et al.
Publicado: (2022)

Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
por: Guan, Bao, et al.
Publicado: (2021)

Prognostic impact of preoperative anemia on upper tract urothelial carcinoma
por: Tan, Ping, et al.
Publicado: (2018)

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma
por: Xiong, Gengyan, et al.
Publicado: (2015)

The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Su, Xiaohong, et al.
Publicado: (2016)

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
por: Tang, Qi, et al.
Publicado: (2023)

Surgical techniques and oncological outcomes of pure transperitoneal laparoscopic radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Yuan, Changwei, et al.
Publicado: (2023)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

Management of Upper Tract Urothelial Carcinoma
por: Smith, Norm D.
Publicado: (2009)

Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma
por: Lu, Huan, et al.
Publicado: (2020)

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy
por: Zhu, Jun, et al.
Publicado: (2022)

Comparison between renal pelvic and ureteral tumors in muscle‐invasive upper tract urothelial carcinoma
por: Qiwei, Chen, et al.
Publicado: (2022)

Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma
por: Bao, Zhengqing, et al.
Publicado: (2019)

Chronic Kidney Disease and Upper Tract Urothelial Carcinomas
por: Wang, Li-Jen, et al.
Publicado: (2014)

AB93. Prognostic and predictive value of epigenetic biomarkers in upper tract urothelial carcinoma: a large-scale multi-gene promoter methylation analysis
por: Xiong, Gengyan, et al.
Publicado: (2014)

Construction and Verification of Immunohistochemistry Parameters-Based Classifier to Predict Local-Recurrence of Upper Tract Urothelial Carcinoma After Kidney-Sparing Surgery
por: Cheng, Xu, et al.
Publicado: (2022)

Trends of incidence and prognosis of upper tract urothelial carcinoma
por: Wu, Jianping, et al.
Publicado: (2021)

The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years
por: Xu, Chunru, et al.
Publicado: (2022)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

AB133. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high volume center of China
por: Xiong, Gengyan, et al.
Publicado: (2014)

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021)

AB051. Comparison of urine cytology and UroVysion FISH for upper tract urothelial carcinoma detection in Chinese patients
por: Peng, Weibin, et al.
Publicado: (2016)

Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma
por: Su, Xiaohong, et al.
Publicado: (2017)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

Endoscopic Management of Upper Tract Urothelial Carcinoma
por: Moore, K., et al.
Publicado: (2009)

Surgical management of upper tract urothelial carcinoma
por: Bird, Vincent G., et al.
Publicado: (2011)

The Role of Chemotherapy in Upper Tract Urothelial Carcinoma
por: O'Donnell, Peter H., et al.
Publicado: (2009)

Comprehensive Management of Upper Tract Urothelial Carcinoma
por: Koukourakis, Georgios, et al.
Publicado: (2009)

Neoadjuvant chemotherapy for upper tract urothelial carcinoma
por: Kim, Do Kyung, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_73lek8ll3h7lg2jimn502p9br7